1 July 2009 in European Journal of Cancer
1 July 2009 in Oman Medical Journal
The objective of this study is to describe the quality of life (QoL) in cancer patients with solid tumors and at different chemotherapy (CT) cycles. A total of 200 cancer patients were included. With some modification, the European Organization for Research and Treatment of Cancer QoL Questionnaire (EORTC QLQ-C30) was used to measure QoL in the student patients. There was no correlation between the QoL and variables such as age, sex, marital status, duration of disease, economic conditions, and occupational function. Furthermore, no correlation was found between QoL and the patients' educational level (literate or illiterate). Nevertheless, a significant difference was found between the level of QoL in patients with ≤ 2 CT cycles and/or with 3-5 cycles (p< 0.001). This study suggests that encouraging cancer patients to complete a CT course plays an important role in the treatment outcome and the QoL in cancer patients undergoing CT.
1 September 2007 in Strahlentherapie und Onkologie
20 November 2015 in RSC Advances
Gold nanoparticles with suitable properties are supreme therapeutic agents and provide effective signal enhancement in photodynamic therapy (PDT). In this study, protoporphyrin IX (PpIX) conjugated gold nanoparticles (GNPs) were prepared using covalent conjugation with cysteine as the adaptable linkage. The thiol group of cysteine was bound to the gold nanoparticles and also the formation of the amide linkage between PpIX and cysteine was confirmed using FT-IR. The spectroscopic characterizations (FT-IR and UV-vis) proved the formation of the PpIX conjugated gold nanoparticles. The reaction process was also followed using thin layer chromatography. Two different laser sources were used to activate the PpIX molecule in the ground state which was highly associated with the amount of singlet oxygen produced. Gold nanoparticles revealed a significant improvement in the singlet oxygen production of the PpIX molecule. The photocytotoxicity of the PpIX conjugated gold nanoparticles was also investigated using spermatogonial cells in vitro. The results confirm that the designed PpIX conjugated gold nanoparticles have provided a highly efficient agent for cellular photodynamic therapy.
1 January 2018 in Journal of Photochemistry and Photobiology B: Biology
1 January 2007 in International Journal of Hyperthermia
Purpose: Patients with recurrent cervical carcinoma within a previously irradiated area respond poorly to chemotherapy. We have treated these patients with simultaneous cisplatin and hyperthermia (CDDP + HT) and investigated response, toxicity, palliative effect and survival. Materials and methods: Between 1992 and 2005 47 patients received CDDP + HT. Response was evaluated by gynaecologic examination and CT-scan. The Common Toxicity Criteria (CTC) were used for evaluation of toxicity and palliative effect. The Kaplan-Meier method was used to estimate survival, and Cox regression analysis to evaluate the influence of prognostic factors. Results: The objective response rate was 55%, palliation was achieved in 74% and operability in 19% of patients. Two patients are currently disease free at 9 years and 18 + months following treatment and 2 remained disease free until death by other causes. The median survival was 8 months and was influenced by duration of disease free interval and tumour diameter. Grade 3–4 haematological toxicity was observed in 36% of patients and renal toxicity was maximum grade 2. Conclusion: CDDP + HT results in a high response rate and acceptable toxicity in patients with recurrent cervical cancer.